Wednesday, 3 March 2021, 4:07 pm
The Lung Cancer Quality Improvement Monitoring Report
released today by Te Aho o Te Kahu, the Cancer Control
Agency, aims to provide information to help District Health
Boards deliver consistent, high-quality cancer
care.
Lung cancer is the leading cause of cancer death
in Aotearoa, New Zealand. It is also a disease which
contributes to inequities within the health system, with
mortality rates three to four times higher for Māori than
non-Māori.
The purpose of the report is to analyse
data from District Health Boards (DHBs) against eight
quality performance indicators (QPIs) to identify
disparities in care and variation in outcomes.
Press Release – Zonta Club of Wellington Seeking natural cures for human ailments based on traditional medicines drives the research of Dr Helen Woolner, the winner of the 2020 Zonta Club of Wellington Science Award. Helen is a chemical scientist and holds a New Zealand Health Research Council …
Seeking natural cures for human ailments based on traditional medicines drives the research of Dr Helen Woolner, the winner of the 2020 Zonta Club of Wellington Science Award.
Helen is a chemical scientist and holds a New Zealand Health Research Council Pacific Post-doctoral Research Fellowship. She is a Health Research Council of New Zealand assessing committee member, and a member of the Te Vairanga Kite Pakari Cook Islands Research Association. Once borders re-open, Helen says “the Zonta prize will allow her to travel to the Helmholtz Centre for Ocean Research in Kiel, Germany”.
Community Scoop » Finding Nature s Cure Drives Zonta Science Award Winner scoop.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scoop.co.nz Daily Mail and Mail on Sunday newspapers.
Subscribe
Vitamin D and asthma: Supplementation did not prevent condition from worsening, except in cases of severe deficiency - RCT By Tingmin Koe High dose of vitamin D supplementation did not prevent the worsening of lung problems, including asthma and COPD, except withing patients already suffering from severe deficiency, according to a RCT conducted in New Zealand.
Writing in
Nutrients, researchers from Harvard Medical School, University of Cambridge, University of Otago and University of Auckland, said the benefits of vitamin D was
“striking” in asthmatic and COPD patients with serum vitamin D at lower than 25nmol/L.
Unexpectedly, the researchers also observed that female patients who took high dose of vitamin D had 46% higher risk of the condition turning for the worse and had to take oral corticosteroid.
ASCOT has partnered with the George Institute for Global Health to oversee the trial in India given its substantial experience operating clinical trials.